Medici List

Ares Core Infrastructure Fund is a Delaware statutory trust and closed-end business development company (BDC) formed in 2024 that invests primarily in North American core infrastructure assets to generate current income and long‑term capital appreciation.

Maryland-incorporated, externally managed, non-diversified closed-end Business Development Company (BDC) focused on originating private credit and related investments in U.S. upper middle-market companies to generate current income and long-term capital appreciation.

Clinical-stage biotechnology company developing orally bioavailable small-molecule inhibitors targeting KRAS-driven and KRAS–PI3Kα–driven cancers.

Clinical-stage company with substantial research and development spending, no reported product revenue in 2025, and net losses of $166,308,000 in 2025 and $80,488,000 in 2024.

a.k.a. Brands Holding Corp. is a portfolio company that owns and operates next-generation fashion brands (Princess Polly, Culture Kings, Petal & Pup, mnml) using a data-driven, omnichannel approach combining digital-first sales with selective stores and wholesale partnerships.

Bowman is a publicly traded professional services firm delivering integrated engineering, technical consulting and program management services for the built environment across the United States.

Amalgamated Financial Corp. is a Delaware public benefit holding company for Amalgamated Bank that markets itself as "America’s Socially Responsible Bank," focused on impact banking, mission-aligned lending, trust and investment management, and ESG/climate finance.

Clinical-stage biotechnology company developing small-molecule and oligonucleotide therapeutics for liver diseases (HBV, MASH/obesity) and viral infections (pan-coronavirus), with in-house CMC and discovery capabilities and multiple pre-commercial Phase 2 programs.

CAMP4 Therapeutics is a clinical-stage biopharmaceutical company developing RNA-targeting antisense oligonucleotide therapies to upregulate gene expression for haploinsufficient CNS genetic diseases, with lead candidate CMP-002 for SYNGAP1-related developmental and epileptic encephalopathy.

Global medical device company specializing in treatments and devices for musculoskeletal pain and injury recovery across Pain Treatments, Surgical Solutions, and Restorative Therapies, with US and International reporting segments.

Blue Owl Capital Corporation II is a closed-end, externally managed business development company that primarily originates and invests in debt (with selective equity) in U.S. middle-market companies to generate current income and secondary capital appreciation.

CPI Card Group Inc. is a U.S.-focused payments technology company that provides end-to-end physical and digital payment card production, personalization, fulfillment and related secure services for financial institutions, processors, fintechs and prepaid program managers.